Tag: PIK3CA

USPSTF recommends chemoprevention for women at high risk for breast cancer

Inavolisib lengthens progression-free survival time in HER2-negative advanced breast cancer

byMichaela Dowlingand1 others

August 26, 2025

1. In this randomized controlled trial, in patients with PIK3CA-mutated advanced breast cancer, the addition of inavolisib to a palbociclib-fulvestrant ...

Ultrasound-guided cryoablation shows promise in treating ductal carcinomas

Inavolisib-Based Therapy in PIK3CA-Mutated Advanced Breast Cancer

byDaniel Goldshteinand1 others

November 11, 2024

1. The median progression-free survival was 15.0 months in the inavolisib and 7.3 months in the placebo group, with HR ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result